Abstract:BACKGROUND: There is extensive scientific evidence that radiation therapy (RT) is a crucial treatment, either alone or in combination with other treatment modalities, for many types of cancer, including breast cancer (BC). BC is a heterogeneous disease at both clinical and molecular levels, presenting distinct subtypes linked to the hormone receptor (HR) status and associated with different clinical outcomes. The aim of this study was to assess the molecular changes induced by high doses of ionizing radiation (IR) on immortalized and primary BC cell lines grouped according to Human epidermal growth factor receptor (HER2), estrogen, and progesterone receptors, to study how HR status influences the radiation response. Our genomic approach using in vitro and ex-vivo models (e.g., primary cells) is a necessary first step for a translational study to describe the common driven radio-resistance features associated with HR status. This information will eventually allow clinicians to prescribe more personalized total doses or associated targeted therapies for specific tumor subtypes, thus enhancing cancer radio-sensitivity.METHODS: Nontumorigenic (MCF10A) and BC (MCF7 and MDA-MB-231) immortalized cell lines, as well as healthy (HMEC) and BC (BCpc7 and BCpcEMT) primary cultures, were divided into low grade, high grade, and healthy groups according to their HR status. At 24 h post-treatment, the gene expression profiles induced by two doses of IR treatment with 9 and 23 Gy were analyzed by cDNA microarray technology to select and compare the differential gene and pathway expressions among the experimental groups.RESULTS: We present a descriptive report of the substantial alterations in gene expression levels and pathways after IR treatment in both immortalized and primary cell cultures. Overall, the IR-induced gene expression profiles and pathways appear to be cell-line dependent. The data suggest that some specific gene and pathway signatures seem to be linked to HR status.CONCLUSIONS: Genomic biomarkers and gene-signatures of specific tumor subtypes, selected according to their HR status and molecular features, could facilitate personalized biological-driven RT treatment planning alone and in combination with targeted therapies.

Effects of BTG2 Overexpression on the Radiosensitivity of Human Breast Cancer T-47D Cells

BTG2 As a Tumor Target for the Treatment of Luminal A Breast Cancer

BTG2 Suppresses the Growth and Metastasis of Cervical Squamous Cell Carcinoma

The effect of BTG1 expression on proliferation, apoptosis and invasion of non-small cell lung cancer cells

Effect of controlling the expression of C-erbB2 on the apoptosis and radiotherapy sensitization of glioma cells

P3.16-01 A Multi-Omic Study Reveals BTG2 As a Reliable Prognostic Marker for Early-Stage Non-Small Cell Lung Cancer

The roles of BTG1 mRNA expression in cancers: A bioinformatics analysis

Transcriptomic Analyses Reveal B-Cell Translocation Gene 2 as a Potential Therapeutic Target in Ovarian Cancer

Genistein Enhances Radiosensitivity of Hepatoma Bel-7404 Cells and Its Possible Mechanisms

TG2 as a novel breast cancer prognostic marker promotes cell proliferation and glycolysis by activating the MEK/ERK/LDH pathway

[The Effect of HER2/neu Overexpression on P53 Gene Expression, Cell Proliferation and Sensitivity to Gamma-Irradiation Via the PI3K/Akt Pathway in Breast Cancer Cell MCF7].

Inhibitory Effects of B‑cell Translocation Gene 2 on Skin Cancer Cells Via the Wnt/β‑catenin Signaling Pathway.

Radiation-Induced Gene Expression Changes in High and Low Grade Breast Cancer Cell Types

Effects of CDX2 Overexpression on Biological Behavior of Gastric Cancer Cells

Targeting Protein for Xenopus Kinesin-Like Protein 2 Knockdown Enhances Radiation Sensitivity of Human Lung Squamous Carcinoma Cell

Expression profile of glioblastoma tissue CXCL14 and IGLV1-44 before-and-after the radiotherapy and its significance

Effect of NDRG2 on proliferation of breast cancer cells

KBTBD2 promotes proliferation and migration of gastric cancer via activating EGFR signaling pathway

Tumor-treating fields elicit a conditional vulnerability to ionizing radiation via the downregulation of BRCA1 signaling and reduced DNA double-strand break repair capacity in non-small cell lung cancer cell lines

Effects of TPX2 gene on radiotherapy sensitization in breast cancer stem cells

The expression of BTG1 is downregulated in NSCLC and possibly associated with tumor metastasis